These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6056042)

  • 1. Irreversible enzyme inhibitors. CVII. Proteolytic enzymes. II. Bulk tolerance within chymotrypsin-inhibitor complexes.
    Baker BR; Hurlbut JA
    J Med Chem; 1967 Nov; 10(6):1129-33. PubMed ID: 6056042
    [No Abstract]   [Full Text] [Related]  

  • 2. Irreversible enzyme inhibitors. 113. Proteolytic enzymes. 3. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides with an N-fluorosulfonylphenyl substituent.
    Baker BR; Hurlbut JA
    J Med Chem; 1968 Mar; 11(2):233-41. PubMed ID: 5654208
    [No Abstract]   [Full Text] [Related]  

  • 3. Irreversible enzyme inhibitors. CXIV. Proteolytic enzymes. IV. Additional active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides bearing a terminal sulfonyl fluoride.
    Baker BR; Hurlbut JA
    J Med Chem; 1968 Mar; 11(2):241-5. PubMed ID: 5654209
    [No Abstract]   [Full Text] [Related]  

  • 4. Irreversible enzyme inhibitors. CXLV. Proteolytic enzymes. 8. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from alpha-(2-carboxy-4-chlorophenoxy)acetamide bearing a terminal sulfonyl fluoride.
    Baker BR; Hurlbut JA
    J Med Chem; 1969 Jan; 12(1):118-22. PubMed ID: 5763006
    [No Abstract]   [Full Text] [Related]  

  • 5. Irreversible enzyme inhibitors. CXXXII. Proteolytic enzymes. VI. Tolerance for polar groups on the phenoxyacetanilide type of inhibitor of alpha-chymotrypsin.
    Baker BR; Hurlbut JA
    J Med Chem; 1968 Sep; 11(5):1054-9. PubMed ID: 5697070
    [No Abstract]   [Full Text] [Related]  

  • 6. INTERACTION OF AROMATIC COMPOUNDS WITH ALPHA-CHYMOTRYPSIN.
    WALLACE RA; KURTZ AN; NIEMANN C
    Biochemistry; 1963; 2():824-36. PubMed ID: 14075122
    [No Abstract]   [Full Text] [Related]  

  • 7. Irreversible enzyme inhibitors. 53. Proteolytic enzymes. XI. Inhibition of guinea pig complement by substituted phenoxyacetamides.
    Baker BR; Hurlbut JA
    J Med Chem; 1969 May; 12(3):415-9. PubMed ID: 5788156
    [No Abstract]   [Full Text] [Related]  

  • 8. Ligand-induced pK changes in chymotrypsin.
    Glick DM
    Biochemistry; 1968 Oct; 7(10):3390-6. PubMed ID: 5681452
    [No Abstract]   [Full Text] [Related]  

  • 9. CHYMOTRYPSIN-CATALYZED HYDROLYSIS OF N-ACETYL- AND N-BENZOYL-L-TYROSINE P-NITROANILIDES.
    BUNDY HF
    Arch Biochem Biophys; 1963 Sep; 102():416-22. PubMed ID: 14072520
    [No Abstract]   [Full Text] [Related]  

  • 10. Demonstration of the acyl-enzyme mechanism for the hydrolysis of peptides and anilides by chymotrypsin.
    Fastrez J; Fersht AR
    Biochemistry; 1973 May; 12(11):2025-34. PubMed ID: 4705984
    [No Abstract]   [Full Text] [Related]  

  • 11. Irreversible enzyme inhibitors. CLXI. Proteolytic enzymes. 13. Inhibitors of guinea pig complement derived by quaternization of 3-acylamidopyridines with alpha-bromomethylbenzenesulfonyl fluorides. II.
    Baker BR; Hurlbut JA
    J Med Chem; 1969 Sep; 12(5):902-5. PubMed ID: 5812209
    [No Abstract]   [Full Text] [Related]  

  • 12. Microenvironmental effects on enzyme catalysis. A kinetic study of polyanionic and polycationic derivatives of chymotrypsin.
    Goldstein L
    Biochemistry; 1972 Oct; 11(22):4072-84. PubMed ID: 5086538
    [No Abstract]   [Full Text] [Related]  

  • 13. [Correlation of enzyme thermostability and its surface hydrophobicity (using a modified alpha-chymotrypsin as an example)].
    Melik-Nubarov NS; Shikshnis VA; Slepnev VI; Shchegolev AA; Mozhaev VV
    Mol Biol (Mosk); 1990; 24(2):346-57. PubMed ID: 2362586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INTERACTION OF AROMATIC COMPOUNDS WITH ALPHA-CHYMOTRYPSIN. II. COMBINATION OF THE ISOMERIC INDOLE CARBOXAMIDES AND CARBOXYLATE IONS WITH THE ACTIVE SITE.
    ABRASH HI; NIEMANN C
    Biochemistry; 1965 Jan; 4():99-104. PubMed ID: 14285251
    [No Abstract]   [Full Text] [Related]  

  • 15. The binding of inhibitors to alpha-chymotrypsin at alkaline pH.
    Johnson CH; Knowles JR
    Biochem J; 1967 May; 103(2):428-30. PubMed ID: 6032980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ON THE DETERMINATION OF TRYPSIN AND CHYMOTRYPSIN WITH AMINO-P-NITROANILIDES].
    NAGEL W; WILLIG F; PESCHKE W; SCHMIDT FH
    Hoppe Seylers Z Physiol Chem; 1965; 340():1-10. PubMed ID: 14312556
    [No Abstract]   [Full Text] [Related]  

  • 17. The binding of inhibitors to alpha-chymotrypsin.
    Johnson CH; Knowles JR
    Biochem J; 1966 Oct; 101(1):56-62. PubMed ID: 5971792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-phenylethaneboronic acid, a possible transition-state analog for chymotrypsin.
    Koehler KA; Lienhard GE
    Biochemistry; 1971 Jun; 10(13):2477-83. PubMed ID: 5557796
    [No Abstract]   [Full Text] [Related]  

  • 19. [A study of conformational changes in alpha-chymotrypsin using the rotatory dispersion method].
    Bolotina IA; Vol'kenshteĭn MV; Chikalova-Luzina OP
    Biokhimiia; 1966; 31(2):241-5. PubMed ID: 5999918
    [No Abstract]   [Full Text] [Related]  

  • 20. Triazines and related products. 8. Potential irreversible chymotrypsin inhibitors: 3-alkyl-1,2,3-benzotriazin-4(3H)-ones and o-azidobenzamides.
    Mair AC; Stevens MF
    J Chem Soc Perkin 1; 1971; 12():2317-24. PubMed ID: 5104591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.